CARRIE DELONG: Open Payments
NPI 1871725556 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,098 in 159 payments from 24 companies in 2025. Trend: 2023 $3,753 · 2024 $3,167 · 2025 $4,098
Food & beverage: $3,237Consulting: $788Education: $74
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $840 |
| Phathom Pharmaceuticals, Inc. | 1 | $788 |
| Novartis Pharmaceuticals Corporation | 16 | $302 |
| Regeneron Healthcare Solutions, Inc. | 17 | $298 |
| GlaxoSmithKline, LLC. | 18 | $274 |
| Amgen Inc. | 16 | $270 |
| CSL Behring | 12 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $207 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $185 |
| ABBVIE INC. | 9 | $144 |
Products named: VOQUEZNA, TEZSPIRE, DUPIXENT, FASENRA, NEFFY, Andembry, RINVOQ, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
